NEU 0.00% $19.97 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-57

  1. 1,564 Posts.
    lightbulb Created with Sketch. 308
    They need to partner for PM P3. We dont have the funds to run it ourself. Thats why its a critical decision as IMO it will rule out anyone other than that partner in makjng a takeover bid.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.